Abstract
To examine whether early treatment intensification using dipeptidyl-peptidase 4 inhibitors (DPP4i) delays insulin initiation in Chinese patients diagnosed with type 2 diabetes for less than 5years. In a territory-wide prospective cohort study, patients with type 2 diabetes initiating DPP4i at diabetes duration <2years (early intensification) and 3-5years (late intensification) were matched using 1:1 propensity-score matching (n=908 in each arm). We used Cox regression to compare the risk of insulin initiation between the two groups. We explored the interactive and mediation effects of glycated haemoglobin (HbA1c) variability score (HVS), defined as the percentage of HbA1c varying by ≥0.5% compared with preceding values. Of 1816 patients (60.7% men, mean age 54.4±11.9years), 92.4% and 71.9% were treated with metformin and sulphonylureas respectively at DPP4i initiation. Early DPP4i intensification [hazard ratio (HR) 0.71, (95% CI 0.58-0.68)] and low HVS (<50%) (HR=0.40, 0.33-0.50) were associated with delayed insulin initiation during a median 4.08years of follow-up. Early intensification with low HVS had the lowest risk versus late intensification with high HVS (HR=0.30, 0.22-0.40) (pinteraction =0.013). HVS mediated 19.5% of the total effect of early DPP4i intensification on delaying insulin initiation. The late and early intensification groups had similar HbA1c at month 0 (8.4±1.3% vs. 8.4±1.5%) and month 3 (7.6±1.2% vs. 7.6±1.3%) after DPP4i initiation. By month 12, HbA1c in the late intensification group deteriorated (7.9±1.4%) but remained stable in the early intensification group (7.6±1.4%, p=0.001) with persistent between-group difference over 72months (8.2±1.7% vs. 7.7±1.6%, p=0.001). In type 2 diabetes, early DPP4i intensification delayed insulin initiation, partially explained by reduced glycaemic variability.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.